Opthea To Participate in Fireside Chat at Oppenheimer’s
MELBOURNE, Australia, March 06, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-03-06, 18:13
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-28, 05:20
Mesoblast Reports Operational and Financial Highlights for
NEW YORK, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-27, 07:46
Mesoblast Financial Results and Corporate Update Webcast
NEW YORK, Feb. 26, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-14, 09:37
Perseus Mining Half year results webinar
Perth, Feb. 14, 2023 (GLOBE NEWSWIRE) -- HALF YEAR REPORT INVESTOR WEBINAR / CALL Perth, Western Australia/February 14, 2023/Perseus Mining Limited...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-14, 08:34
Half Year Results Briefing
BRISBANE, Australia, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Allkem Limited (ASX|TSX: AKE) (“Allkem” or “the Company”) will release its FY23 Half Year...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-10, 11:31
Passing of Chief Financial Officer – Mr Neil Kaplan
BRISBANE, Australia, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Allkem Limited (ASX|TSX: “Allkem,” the Company”) advises with great sadness that Chief Financial...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-01-30, 05:21
Change to Perseus's Senior Management Team
Perth, Jan. 30, 2023 (GLOBE NEWSWIRE) -- CHANGE TO PERSEUS’S SENIOR MANAGEMENT TEAM Perth, Western Australia/January 30, 2023/Perseus Mining Limited...
